Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Oncology (Williston Park, N.Y.)|June 4, 2010
Best practices in the management of newly diagnosed multiple myeloma patients who will not undergo transplantRuben Niesvizky, Morton Coleman, Tomer MarkFuture Oncology (London, England)|November 17, 2021
Real-world outcomes of pomalidomide therapy after lenalidomide induction in relapsed/refractory multiple myelomaTomer Mark, Angelica Falkenstein, Jonathan KishExpert Opinion on Investigational Drugs|December 5, 2008
Milatuzumab: a promising new agent for the treatment of lymphoid malignanciesTomer Mark, Peter Martin, John P Leonard, et al.Transfusion|January 11, 2012
Factor VIII/von Willebrand factor concentrate therapy for ventricular assist device-associated acquired von Willebrand diseaseMelissa Cushing, Kathy Kawaguchi, Kenneth D Friedman, et al.Cancer Treatment Reviews|May 22, 2012
Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairmentMeletios A Dimopoulos, Evangelos Terpos, Hartmut Goldschmidt, et al.Journal of Clinical Medicine|June 26, 2025
Focusing on Selinexor for Holding and Bridging Prior to CAR-T in Relapsed/Refractory Multiple MyelomaJack Khouri, Douglas Sborov, Adriana Rossi, et al.Transfusion|March 27, 2015
A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumerationEmily Storch, Tomer Mark, Scott Avecilla, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 13, 2025
Immature Platelets and Platelet Reactivity in Patients with COVID-19Yulia Balmakov, Tomer Mark, Itzik Barnett, et al.Cancer|September 24, 2010
Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myelomaRuben Niesvizky, Scott Ely, Tomer Mark, et al.Blood|January 10, 2013
BiRd (clarithromycin, lenalidomide, dexamethasone): an update on long-term lenalidomide therapy in previously untreated patients with multiple myelomaAdriana Rossi, Tomer Mark, David Jayabalan, et al.Pageof 4